Clinical Trial Update: Bioequivalence Study to Compare Empagliflozin/ Metformin HCl 12.5mg/1000mg Film-coated Tablets [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study evaluating a fixed-dose combination tablet of empagliflozin and metformin HCl (12.5 mg/1000 mg) has completed. The study target pop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin/metformin HCl 12.5 mg/1000 mg film-coated tablets (Empagliflozin/metformin)

Snippet

Sponsor: Humanis Saglık Anonim Sirketi | Conditions: Type2diabetes | Phase 1 | Status: COMPLETED